Profile data is unavailable for this security.
About the company
Taidoc Technology Corp is a Taiwan-based company mainly engaged in the manufacture and sale of medical equipment. The main products include diagnostic testing instruments and reagents, home medical instruments, professional medical monitoring equipment and telemedicine products. The diagnostic test instruments include blood glucose monitors and blood glucose test chips, blood glucose measurement systems, glycated hemoglobin meters. The home medical instruments include ear thermometers, electronic sphygmomanometers, nebulizers. The professional medical monitoring equipment include equipment for monitoring changes in physiological parameters such as blood glucose, blood pressure, blood oxygen concentration, electrocardiogram and body temperature in hospitals and clinics. The telemedicine products include medical products with network connection functions. The Company operates within the domestic market and to overseas markets, including the Americas, Europe, Middle East and Asia.
- Revenue in TWD (TTM)4.35bn
- Net income in TWD1.02bn
- Incorporated1998
- Employees829.00
- LocationTaidoc Technology Corp6FNo.127, Wugong 2 nd Road, Wugu DistrictNEW TAIPEI 248TaiwanTWN
- Phone+886 266258188
- Fax+886 266250288
- Websitehttps://taidoc.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHC Healthcare Group | 3.73bn | 341.88m | 7.79bn | 160.00 | 25.17 | 1.26 | 8.44 | 2.09 | 1.86 | 1.86 | 19.97 | 36.92 | 0.2753 | 4.08 | 3.97 | -- | 2.52 | 3.23 | 3.00 | 3.80 | 26.37 | 30.12 | 9.15 | 13.16 | 2.01 | 10.78 | 0.455 | 81.75 | 30.35 | 9.11 | 17.47 | 5.31 | 9.69 | 2.25 |
| Excelsior Medical Co Ltd | 8.27bn | 729.96m | 13.82bn | 774.00 | 19.00 | 1.66 | 11.90 | 1.67 | 4.67 | 4.67 | 52.96 | 53.65 | 0.4706 | 5.36 | 5.48 | -- | 5.14 | 4.94 | 10.49 | 9.25 | 20.25 | 20.22 | 10.91 | 10.60 | 1.28 | -- | 0.0914 | 83.22 | 14.56 | 5.35 | 11.86 | 10.58 | 31.53 | 7.24 |
| Vizionfocus Inc | 2.83bn | 654.83m | 13.92bn | -- | 19.93 | 4.35 | 13.25 | 4.92 | 12.14 | 12.14 | 52.60 | 55.63 | 0.6401 | 6.99 | 6.07 | -- | 17.03 | 12.00 | 22.00 | 16.54 | 40.90 | 37.01 | 26.60 | 20.52 | 2.90 | -- | 0.2795 | 28.73 | 40.23 | 52.18 | 79.65 | 233.89 | 71.42 | -- |
| Taidoc Technology Corp | 4.35bn | 1.02bn | 15.50bn | 829.00 | 15.19 | 1.67 | 12.09 | 3.57 | 10.70 | 10.70 | 45.43 | 97.11 | 0.3468 | 1.95 | 3.98 | -- | 8.51 | 17.60 | 11.73 | 22.98 | 40.63 | 50.73 | 24.55 | 28.49 | 3.14 | -- | 0.0659 | 68.99 | -50.07 | 2.03 | -69.93 | 3.02 | -34.71 | 4.58 |
| Visco Vision Inc | 2.69bn | 432.93m | 16.10bn | -- | 37.24 | 5.38 | 19.33 | 5.99 | 6.86 | 6.86 | 42.60 | 47.46 | 0.5397 | 2.85 | 5.99 | -- | 8.56 | 11.68 | 11.17 | 15.80 | 39.40 | 40.56 | 15.86 | 17.72 | 1.16 | 21.32 | 0.2707 | 43.00 | -13.68 | 25.82 | -51.15 | 8.74 | 0.8293 | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Jul 2024 | 2.57m | 2.70% |
| Dimensional Fund Advisors LPas of 04 Jul 2024 | 1.16m | 1.22% |
| BlackRock Fund Advisorsas of 04 Jul 2024 | 862.00k | 0.90% |
| Cambria Investment Management LPas of 03 Jul 2024 | 726.00k | 0.76% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 587.00k | 0.62% |
| Grantham, Mayo, Van Otterloo & Co. LLCas of 29 Feb 2024 | 339.00k | 0.36% |
| Franklin Templeton SinoAm Securities Investment Mgmt, Incas of 31 Dec 2023 | 300.00k | 0.32% |
| BlackRock Advisors (UK) Ltd.as of 04 Jul 2024 | 153.00k | 0.16% |
| State Board of Administration of Florida Retirement Systemas of 30 Jun 2023 | 147.90k | 0.16% |
| Jennison Associates LLCas of 30 Sep 2023 | 116.00k | 0.12% |
